Loading...

Fixation Buffer Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL NOK487
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  2. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  3. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  4. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  5. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  6. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  7. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  8. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  9. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  10. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  11. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  12. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  13. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  14. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  15. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  16. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  17. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  18. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  19. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  20. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  21. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  22. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  23. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  24. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  25. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  26. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  27. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  28. Chan L, et al. 2022. Cells. 12: . PubMed
  29. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  30. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  31. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  32. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  33. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  34. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  35. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  36. Zander R, et al. 2022. Immunity. 55:475. PubMed
  37. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  38. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  39. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  40. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  41. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  42. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  43. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  44. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  45. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  46. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  47. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  48. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  49. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  50. Wang H, et al. 2023. Nature. 615:339. PubMed
  51. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  52. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  53. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  54. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  55. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  56. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  57. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  58. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  59. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  60. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  61. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  62. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  63. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  64. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  65. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  66. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  67. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  68. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  69. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  70. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  71. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  72. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  76. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  77. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  78. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  79. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  80. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  81. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  82. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  83. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  84. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  85. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  86. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  87. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  88. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  89. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  90. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  91. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  92. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  93. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  94. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  95. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  96. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  97. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  98. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  99. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  100. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  101. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  102. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  103. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  104. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  105. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  106. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  107. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  108. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  109. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  110. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  111. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  112. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  113. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  114. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  115. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  116. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  117. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  118. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  119. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  121. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  122. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  123. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  124. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  125. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  126. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  127. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  128. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  129. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  130. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  136. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  137. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  138. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  139. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  140. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  141. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  142. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  143. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  144. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  145. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  146. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  147. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  148. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  149. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  150. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  151. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  154. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  155. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  156. Ma K, et al. 2022. iScience. 25:104347. PubMed
  157. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  158. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  159. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  160. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  161. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  162. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  163. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  164. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  165. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  166. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  167. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  168. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  169. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  170. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  171. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  172. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  173. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  174. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  175. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  176. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  177. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  178. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  179. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  180. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  181. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  182. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  183. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  184. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  185. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  186. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  187. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  188. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  189. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  190. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  191. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  192. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  193. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  194. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  195. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  196. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  197. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  198. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  199. Wang X, et al. 2022. Elife. 11:. PubMed
  200. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  201. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  202. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  203. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  204. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  205. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  206. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  207. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  208. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  209. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  210. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  212. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  215. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  216. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  217. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  218. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  219. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  220. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  221. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  222. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  223. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  224. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  225. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  226. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  227. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  228. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  229. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  230. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  231. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  232. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  233. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  234. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  235. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  236. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  237. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  238. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  239. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  240. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  241. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  242. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  243. Chan L, et al. 2022. Cells. 12: . PubMed
  244. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  245. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  246. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  247. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  248. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  249. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  250. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  251. Zander R, et al. 2022. Immunity. 55:475. PubMed
  252. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  253. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  254. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  255. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  256. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  257. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  258. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  259. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  260. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  261. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  262. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  263. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  264. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  265. Wang H, et al. 2023. Nature. 615:339. PubMed
  266. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  267. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  268. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  269. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  270. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  271. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  272. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  273. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  274. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  275. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  276. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  277. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  278. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  279. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  280. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  281. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  282. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  283. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  284. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  285. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  286. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  287. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  288. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  289. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  290. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  291. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  292. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  293. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  294. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  295. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  296. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  297. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  298. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  299. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  300. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  301. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  302. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  303. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  304. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  305. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  306. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  307. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  308. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  309. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  310. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  311. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  312. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  313. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  314. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  315. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  316. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  317. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  318. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  319. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  320. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  321. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  322. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  323. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  324. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  325. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  326. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  327. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  328. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  329. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  330. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  331. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  332. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  333. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  334. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  335. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  336. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  337. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  338. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  339. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  340. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  341. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  342. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  343. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  344. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  345. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  346. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  347. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  348. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  349. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  350. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  351. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  352. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  353. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  354. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  355. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  356. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  357. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  358. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  359. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  360. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  361. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  362. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  363. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  364. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  365. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  366. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  367. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  368. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  369. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  370. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  371. Ma K, et al. 2022. iScience. 25:104347. PubMed
  372. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  373. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  374. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  375. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  376. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  377. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  378. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  379. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  380. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  381. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  382. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  383. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  384. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  385. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  386. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  387. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  388. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  389. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  390. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  391. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  392. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  393. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  394. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  395. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  396. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  397. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  398. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  399. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  400. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  401. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  402. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  403. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  404. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  405. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  406. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  407. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  408. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  409. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  410. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  411. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  412. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  413. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  414. Wang X, et al. 2022. Elife. 11:. PubMed
  415. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  416. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  417. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  418. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  419. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  420. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  421. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  422. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  423. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  424. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  425. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  426. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  427. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  430. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07.25.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL NOK487
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  2. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  3. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  4. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  5. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  6. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  7. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  8. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  9. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  10. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  11. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  12. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  13. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  14. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  15. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  16. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  17. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  18. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  19. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  20. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  21. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  22. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  23. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  24. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  25. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  26. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  27. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  28. Chan L, et al. 2022. Cells. 12: . PubMed
  29. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  30. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  31. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  32. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  33. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  34. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  35. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  36. Zander R, et al. 2022. Immunity. 55:475. PubMed
  37. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  38. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  39. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  40. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  41. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  42. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  43. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  44. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  45. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  46. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  47. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  48. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  49. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  50. Wang H, et al. 2023. Nature. 615:339. PubMed
  51. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  52. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  53. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  54. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  55. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  56. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  57. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  58. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  59. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  60. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  61. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  62. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  63. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  64. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  65. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  66. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  67. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  68. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  69. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  70. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  71. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  72. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  76. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  77. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  78. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  79. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  80. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  81. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  82. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  83. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  84. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  85. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  86. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  87. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  88. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  89. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  90. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  91. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  92. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  93. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  94. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  95. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  96. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  97. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  98. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  99. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  100. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  101. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  102. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  103. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  104. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  105. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  106. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  107. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  108. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  109. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  110. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  111. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  112. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  113. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  114. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  115. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  116. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  117. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  118. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  119. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  121. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  122. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  123. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  124. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  125. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  126. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  127. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  128. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  129. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  130. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  134. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  135. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  136. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  137. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  138. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  139. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  140. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  141. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  142. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  143. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  144. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  145. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  146. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  147. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  148. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  149. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  150. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  151. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  154. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  155. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  156. Ma K, et al. 2022. iScience. 25:104347. PubMed
  157. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  158. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  159. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  160. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  161. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  162. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  163. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  164. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  165. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  166. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  167. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  168. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  169. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  170. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  171. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  172. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  173. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  174. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  175. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  176. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  177. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  178. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  179. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  180. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  181. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  182. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  183. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  184. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  185. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  186. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  187. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  188. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  189. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  190. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  191. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  192. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  193. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  194. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  195. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  196. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  197. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  198. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  199. Wang X, et al. 2022. Elife. 11:. PubMed
  200. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  201. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  202. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  203. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  204. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  205. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  206. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  207. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  208. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  209. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  210. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  212. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  215. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  216. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  217. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  218. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  219. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  220. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  221. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  222. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  223. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  224. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  225. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  226. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  227. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  228. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  229. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  230. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  231. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  232. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  233. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  234. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  235. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  236. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  237. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  238. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  239. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  240. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  241. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  242. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  243. Chan L, et al. 2022. Cells. 12: . PubMed
  244. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  245. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  246. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  247. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  248. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  249. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  250. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  251. Zander R, et al. 2022. Immunity. 55:475. PubMed
  252. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  253. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  254. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  255. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  256. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  257. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  258. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  259. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  260. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  261. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  262. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  263. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  264. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  265. Wang H, et al. 2023. Nature. 615:339. PubMed
  266. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  267. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  268. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  269. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  270. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  271. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  272. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  273. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  274. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  275. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  276. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  277. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  278. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  279. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  280. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  281. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  282. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  283. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  284. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  285. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  286. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  287. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  288. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  289. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  290. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  291. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  292. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  293. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  294. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  295. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  296. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  297. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  298. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  299. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  300. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  301. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  302. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  303. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  304. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  305. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  306. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  307. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  308. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  309. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  310. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  311. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  312. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  313. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  314. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  315. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  316. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  317. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  318. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  319. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  320. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  321. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  322. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  323. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  324. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  325. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  326. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  327. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  328. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  329. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  330. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  331. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  332. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  333. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  334. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  335. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  336. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  337. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  338. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  339. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  340. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  341. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  342. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  343. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  344. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  345. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  346. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  347. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  348. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  349. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  350. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  351. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  352. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  353. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  354. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  355. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  356. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  357. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  358. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  359. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  360. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  361. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  362. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  363. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  364. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  365. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  366. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  367. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  368. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  369. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  370. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  371. Ma K, et al. 2022. iScience. 25:104347. PubMed
  372. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  373. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  374. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  375. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  376. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  377. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  378. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  379. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  380. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  381. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  382. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  383. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  384. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  385. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  386. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  387. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  388. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  389. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  390. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  391. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  392. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  393. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  394. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  395. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  396. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  397. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  398. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  399. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  400. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  401. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  402. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  403. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  404. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  405. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  406. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  407. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  408. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  409. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  410. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  411. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  412. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  413. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  414. Wang X, et al. 2022. Elife. 11:. PubMed
  415. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  416. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  417. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  418. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  419. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  420. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  421. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  422. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  423. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  424. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  425. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  426. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  427. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  430. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07.25.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account